Insecticides Flashcards

1
Q

Organochlorine insecticides

A

-banned for use in Canada and USA… used in 1950s-1970s
-very persistent in environment (bioaccumulation, bioconcentration, biomagnification)
-modern poisonings uncommon but sometimes in old barns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Organochlorine insecticide options

A

-DDT
-methoxychlor
-lindane
-dieldrin
-chlordane
-aldrin
-endosulfan
-hepatochlor
-toxaphene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of organochlorine insecticides

A

Interfere with action potentials and NTs in CNS

ex.
-DDT- interacts with Na and K influx/efflux
-GABA inhibition
-Enhanced acetylcholine release
-CNS excitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxokinetics for organochlorine insecticides

A

-High lipophilicity (partition to fatty acids (brain and adipose), excreted in milk)

-very long elimination half life (months; enterohepatic recirculation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Onset of organochlorine insecticides

A

Within hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical signs of organochlorine insecticides

A
  1. Behaviour changes (anxiety, agitation/aggression, jumping over invisible objects)
  2. GI (vomiting and saliva)
  3. CNS excitation (tremors, tonic clonic seizures, opisthotonus, paddling, jaw clamping, circling, stiff gait)
  4. progresses to coma and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Management of organochlorine insecticides

A

-decontamination if not contraindicated= dermal wash

-anticonvulsants, methocarbamol, fluids, O2, mechanical ventilation, ILE, cholestyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis for organochlorine insecticides

A

Some have pesticide screenings (for fat, liver, brain, gastric contents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Public health implications for organochlorine insecticides

A

-long elimination half life
-human health concerns (endocrine disruption, carcinogenic)
-food animal residues
-persistent in environment; negative impact on wildlife populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Organophosphate and carbamate

A

-most common group of pesticides/insecticides
*highly toxic but not environmentally persistent

-same mechanism of organochloride insecticides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are organophosphate and carbamate insecticides used for?

A

-agriculture use
-flea and tick treatments
-shampoos
-dips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do animals get exposed to organophosphate and carbamates?

A

-malicious poisoning
-accidental- access to chemicals, ingestion of cattle ear tags, spraying, treated crops, poisonied insects/animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanism of action of organophosphates and carbamates

A

Inhibition of acetylcholinesterase preventing acetylcholine breakdown and therefore the overstimulation of nicotinic and muscarinic receptors

*leads to CNS, neuromuscular junction, parasympathetic nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Differences between organophosphates and carbamates

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical presentations of organophosphate and carbamate toxicity

A
  1. acute toxicosis
  2. intermediate syndrome
  3. OP-induced delayed polyneuropathy (OPIDPN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute toxicosis route of exposure and onset of organophosphates and carbamates

A

-routes: ingestion, inhalation, dermal

-onset: as early as 15mins post exposure

17
Q

3 categories of symptoms for acute toxicosis of organophosphates and carbamates

A
  1. symptoms from mAChR overstimulation
    2.symptoms related to nAChR overstimulation
  2. Symptoms related to CNS overstimulation
18
Q

Symptoms from mAChR overstimulation

19
Q

Symptoms from nAChR overstimulation

20
Q

Symptoms from CNS overstimulation

21
Q

How do organophosphates and carbamates cause acute toxicosis death?

A

-bronchoconstriction/bronchorrhea
-respiratory failure and hypoxia

22
Q

Post mortem findings from acute toxicosis of organophosphate and carbamates

A

-No specific lesions (edema, congestion and hemorrhage present)
-can see insecticide granules or bait in stomach/rumen

23
Q

Intermediate syndrome of organophosphate and carbamates toxicity

A

-dogs and cats
-Onset: 24-96hrs after surviving acute cholinergic crisis

24
Q

Clinical signs of intermediate syndrome from organophosphate and carbamate toxicity

A
  1. Acute muscular weakness: abnormal posture, cervical ventroflexion, resp muscle weakness and depression
  2. Decreased acetylcholinesterase activity
25
Q

Cause of OP-induced delayed polyneuropathy (OPIDPN) from organophosphates and carbamates

A

Due to degeneration of long motor nerves by the inhibition of neuropathy target esterase (NTE)
-axonopathy, myelinopathy

26
Q

Onset and clinical signs of OP-induced delayed polyneuropathy (OPIDPN) organophosphate and carbamate toxicity

A

Onset: 1-4weeks after exposure to OP

Signs: ataxia, pelvic limb weakness, normal blood acetylcholinesterase

27
Q

Management for acute toxicosis of organophosphate and carbamate toxicity

A

-Antidote= atropine to control bradycardia and bronchial secretions
*use a test dose first

-if known exposure (sometimes if unknown), may need to add in oximes (2-PAM) prior to enzyme aging

28
Q

What to do if there is no history of organophosphate or carbamate exposure, but signs suggest cholinergic toxidrome?

A

Test dose atropine. If pupil dilation, increased HR, and salivation stops within 10-15mins then STOP, not toxicity. If not give more atropine

29
Q

Basic supportive care for acute toxicosis

A

-O2, mechanical vent
-fluids
-seizure control
-anti-emetics

30
Q

Management for intermediate syndrome

A

-no atropine because muscarinic signs not present
-2-PAM
-supportive care
-slow recovery

31
Q

Management for OPIDPN

A

-no atropine because muscarinic signs not present
-supportive care

32
Q

Diagnosis for organophosphate and carbamates

A

-history
-response to atropine
-antemortem: AChE activity of heparinized whole blood
*less than 50%=suspicious, less than 25%=diagnostic
-postmortem: brain AChE activity (freeze half of brain)
-analysis of stomach, urine, other tissues

33
Q

Diagnosis of OPIDN

A

-history of exposure
-no specific gross lesions
-histo of nerves= Wallerian degeneration
-NTE test but not available in diagnostic lab